Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer

JAMA. 2024 Oct 1;332(13):1113. doi: 10.1001/jama.2024.15491.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Aspirin* / administration & dosage
  • Breast Neoplasms* / mortality
  • Breast Neoplasms* / pathology
  • Breast Neoplasms* / therapy
  • Chemotherapy, Adjuvant / methods
  • Clinical Trials, Phase III as Topic
  • Disease-Free Survival
  • Female
  • Humans
  • Multicenter Studies as Topic
  • Neoplasm Invasiveness / prevention & control
  • Neoplasm Recurrence, Local / epidemiology
  • Neoplasm Recurrence, Local / prevention & control
  • Placebos / administration & dosage
  • Randomized Controlled Trials as Topic

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Aspirin
  • Placebos